Rethinking Clinical Trials

FEBRUARY 9, 2023

The trial was designed before the COVID-19 pandemic, but it was conducted during the height of the pandemic in New York. Because of rebalancing of physicians, there were more COVID-19 patients in the intervention group. What is the explanation for the excess deaths at 30 days in the intervention group?

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

JULY 14, 2023

Tyson School of Medicine Slides Keywords Pragmatic Clinical Trial, GGC4H, Prevention Key Points Guiding Good Choices for Health Study (GGC4H) is about the Guiding Good Choices (GGC) intervention, a group-based program for parents and caregivers of younger adolescents (ages 9-14). 2) Can virtual GGC be delivered with fidelity?

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

FEBRUARY 13, 2023

COVID-19 absorbed everyone in the middle of the trial. The design of platform trials can build on the lessons learned from this study. – Why didn’t you start to design the follow-on trial while you were still in the field?

Trials 130

Trials Clinical Trials Clinical Trials Research 130

Rethinking Clinical Trials

SEPTEMBER 16, 2022

Has COVID-19 shifted the dynamic of Learning Health Systems, and if so, how? There might be an opportunity to learn from the lessons of Covid. Steven Joffe, MD, MPH. Art and Ilene Penn Professor and Chair. Department of Medical Ethics & Health Policy. University of Pennsylvania Perelman School of Medicine. Key Points.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Research 100

Rethinking Clinical Trials

JULY 6, 2023

During the COVID-19 pandemic, several regulatory authorities around the world introduced guidance on DCTs. There has been a growing sense of hesitancy about whether regulators will remain equally receptive to these decentralized methods when the pandemic recedes.

Trials 130

Trials Clinical Trials Clinical Trials Licensing 130

Rethinking Clinical Trials

AUGUST 30, 2023

   Speaker Gabriela Schmajuk, MD, MS Professor of Medicine UCSF and the San Francisco VA Slides Keywords Patient-Reported Outcomes, Rheumatoid Arthritis, EHR Key Points Clinicians rely on patient-related outcomes (PROs) to track disease and function over time in patients with rheumatoid arthritis (RA).

Trials 141

Trials Clinical Research Coordinator Medicine Clinical Trials 141

Rethinking Clinical Trials

NOVEMBER 21, 2022

– What challenges did you face due to COVID-19? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speakers. Padmanabhan Ramnarayan, MBBS, MD, FRCPCH, FFICM. Reader in Pediatric Critical Care. Imperial College London. Pragmatic Clinical Trials. Key Points. We had monthly teleconferences – some clinicians were not fussed about it.

Trials 130

Trials Clinical Trials Clinical Trials Packaging 130

Rethinking Clinical Trials

AUGUST 28, 2023

Food and Drug Administration (FDA) Slides Keywords Pragmatic trials; Research; Guidance, Regulatory, Data Governance Key Points The clinical trial enterprise needs modernization. The work started before COVID-19, and the idea was to meet every six months. We had an opportunity to meet once, and then everything became virtual.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

AUGUST 28, 2023

Food and Drug Administration (FDA) Slides Keywords Pragmatic trials; Research; Guidance, Regulatory, Data Governance Key Points The clinical trial enterprise needs modernization. The work started before COVID-19, and the idea was to meet every six months. We had an opportunity to meet once, and then everything became virtual.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

pharmaphorum

NOVEMBER 13, 2020

Since Covid-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying on e-commerce and digital engagement to counterbalance the reduced ability for physical interactions. As with Google, use target keywords relevant to your audience. How to make the move from physical to digital.

Branding 122

Branding Pharmacy Marketing Compliance 122

Rethinking Clinical Trials

DECEMBER 6, 2022

Enrollment halted before planned sample size of 200 due to COVID-19.                                           . Speakers. Michael Felker, MD, MHS. Professor of Medicine. Director, Cardiovascular and Metabolism Research, DCRI. Pragmatic Clinical Trials, Heart Failure, Diabetes. Key Points.

Trials 130

Trials Clinical Trials Clinical Trials Compliance 130

Rethinking Clinical Trials

JULY 19, 2023

Key study limitations were the need for remote delivery due to the COVID-19 pandemic and the lack of total representation of the broader U.S. Distinguished Professor of Medicine Professor of Nursing Duke University Neha J. or international population across the selected sites and patients.

Trials 130

Trials Cardiology Medicine Nurses 130

Rethinking Clinical Trials

MAY 5, 2023

Assistant Professor of Medicine and Biomedical Informatics Medical Director, VICTR Center for Learning Healthcare Vanderbilt University Medical Center Slides Keywords Pragmatic Clinical Trials, Cluster-crossover Trial Key Points More than 3 million adults receive invasive mechanical ventilation each year in the U.S. Semler, M.D.,

Trials 130

Trials Clinical Trials Clinical Trials Development 130

World of DTC Marketing

AUGUST 16, 2020

Pharma will spend hundreds of thousands of dollars on Google keywords but they won’t do usability testing as part of their website development. Today, pharma CEOs make tens of millions of dollars because of one goal: sales. The CEO of AbbVie is actually compensated for his ability to fight off patent challenges on their top drug Humira.

Sales 196

Sales Drugs Insulin Development 196

pharmaphorum

OCTOBER 21, 2021

One area that has affected every healthcare professional, indeed almost every person on earth, has been the COVID-19 pandemic. When users reply to a thread mentioning the bot and using the keyword “unroll” the bot comments returning a link to the full thread in one article.

Doctors 126

Doctors Doctor Trials Research 126

XTalks

JANUARY 5, 2022

Life science organizations are facing immense pressure by the government, the general public and regulators due to COVID-19 and its emerging variants. Some of the features include our job category search with optimized keyword search, which helps the best candidates find your job posting faster.

Life Science 104

Life Science Branding Regulation Production 104

Bioengineer

JULY 21, 2021

Researchers first to model COVID-19 completion vs. cessation study using machine learning. In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices and re-purposed drugs are urgently needed. In addition, these models also can predict COVID-19 trial status with satisfactory accuracy.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Engineer 52

Rethinking Clinical Trials

OCTOBER 24, 2023

REMAP-CAP offered operational and statistical efficiencies, addressing challenges associated with the COVID-19 pandemic. A post hoc analysis evaluated strategies for further studying heterogeneity of treatment effect.

Trials 130

Trials Clinical Trials Clinical Trials Cardiology 130

pharmaphorum

DECEMBER 14, 2020

Furthermore, the COVID-19 pandemic ensures an ongoing state of evolution. This was seen during the first COVID-19 lockdowns: when people started talking about ‘social distancing’, too many brands responded by removing graphical elements of their logos to symbolise that distancing. But look at the three logos below.

Branding 127

Branding Engineer Life Science Nurses 127

Rethinking Clinical Trials

AUGUST 4, 2022

TOGETHER, COVID-19, Peginterferon Lambda. TOGETHER is a randomized adaptive platform trial that was initiated in June 2020 to investigate the efficacy of repurposed treatments for COVID-19 disease among high-risk adult outpatients. Grant Professor and Professor of Microbiology and Immunology. Stanford University.

Trials 130

Trials Vaccination Vaccine Clinical Trials 130

XTalks

DECEMBER 8, 2021

Lastly, you can have a column for specific keywords or a general webinar summary for each webinar as well. . How to leverage the experiences we have gained during the COVID-19 pandemic to address the need for accelerating pediatric medicines and vaccines development .

Marketing 103

Marketing Clinical Development Production Branding 103

Rethinking Clinical Trials

AUGUST 11, 2022

The platform trial model is not easy but not impossible; as we saw during the COVID-19 pandemic, it can be an effective way to discover important therapies and research in a fast and effective manner. ?. Speaker. Jay JH Park, PhD, MSc. Assistant Professor. Department of Health Research Methods, Evidence and Impact. McMaster University.

Trials 130

Trials Clinical Trials Clinical Trials Research 130

Rethinking Clinical Trials

NOVEMBER 9, 2022

The biggest inflection point for CardioNerds was COVID-era recruitment, when residents were asked to decide where to train for fellowship without having in-person visits. Like many trials during the COVID-19 pandemic, there were significant challenges and recruitment delays. Amit Goyal, MD, MAS. Cofounder of CardioNerds.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130